{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:20:06Z","timestamp":1793305206547,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s40271-023-00619-w","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T11:03:42Z","timestamp":1679483022000},"page":"183-199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["So You Want to Build Your Disease\u2019s First Online Patient Registry: An Educational Guide for Patient Organizations Based on US and European Experience"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2293-9284","authenticated-orcid":false,"given":"Paul","family":"Wicks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9861-3782","authenticated-orcid":false,"given":"Lindsey","family":"Wahlstrom-Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5224-4996","authenticated-orcid":false,"given":"Sam","family":"Fillingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Downing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4987-0088","authenticated-orcid":false,"given":"Elin Haf","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"619_CR1","doi-asserted-by":"crossref","unstructured":"Gliklich RE, Leavy MB, Dreyer NA. Registries for evaluating patient outcomes: a user\u2019s guide. Fourth edition. Agency for Healthcare Research and Quality (AHRQ); 2020. https:\/\/effectivehealthcare.ahrq.gov\/products\/registries-guide-4th-edition\/users-guide. Accessed 9 Mar 2023.","DOI":"10.23970\/AHRQEPCREGISTRIES4"},{"key":"619_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3319","author":"EC Nelson","year":"2016","unstructured":"Nelson EC, Dixon-Woods M, Batalden PB, Homa K, Van Citters AD, Morgan TS, et al. Patient focused registries can improve health, care, and science. BMJ. 2016. https:\/\/doi.org\/10.1136\/bmj.i3319.","journal-title":"BMJ"},{"key":"619_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/lrh2.10028","volume":"1","author":"S Okun","year":"2017","unstructured":"Okun S, Goodwin K. Building a learning health community: by the people, for the people. Learn Health Syst. 2017;1: e10028.","journal-title":"Learn Health Syst."},{"key":"619_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40900-016-0047-6","volume":"2","author":"M Bradley","year":"2016","unstructured":"Bradley M, Braverman J, Harrington M, Wicks P. Patients\u2019 motivations and interest in research: characteristics of volunteers for patient-led projects on PatientsLikeMe. Res Involv Engagem. 2016;2:33.","journal-title":"Res Involv Engagem."},{"key":"619_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101019","volume":"38","author":"HE Davis","year":"2021","unstructured":"Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Reem Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38: 101019.","journal-title":"eClinicalMedicine."},{"key":"619_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1212\/WNL.0000000000000669","volume":"83","author":"E Landfeldt","year":"2014","unstructured":"Landfeldt E, Lindgren P, Bell CF, Schmitt C, Guglieri M, Straub V, et al. The burden of Duchenne muscular dystrophy: an international, cross-sectional study. Neurology. 2014;83:529\u201336.","journal-title":"Neurology"},{"key":"619_CR7","unstructured":"European Medicines Agency. Patient Registries Workshop, 28 October 2016. 2017. https:\/\/www.ema.europa.eu\/en\/documents\/report\/report-patient-registries-workshop_en.pdf. Accessed 9 Mar 2023."},{"key":"619_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13023-017-0635-z","volume":"12","author":"J Muenzer","year":"2017","unstructured":"Muenzer J, Jones SA, Tylki-Szyma\u0144ska A, Harmatz P, Mendelsohn NJ, Guffon N, et al. Ten years of the Hunter Outcome Survey (HOS): insights, achievements, and lessons learned from a global patient registry. Orphanet J Rare Dis. 2017;12:82.","journal-title":"Orphanet J Rare Dis"},{"key":"619_CR9","unstructured":"TREAT-NMD Neuromuscular Network. TREAT-NMD diseases: data and Information. 2022. https:\/\/treat-nmd.org\/what-we-do\/data-and-information\/treat-nmd-diseases\/. Accessed 9 Mar 2023."},{"key":"619_CR10","unstructured":"Maelstrom. Multiple Sclerosis Metadata Collective: a collaborative effort of North American observational studies in multiple sclerosis. 2022. https:\/\/www.maelstrom-research.org\/network\/msmdc. Accessed 24 Oct 2022."},{"key":"619_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/cpt.1414","volume":"106","author":"CA Olmo","year":"2019","unstructured":"Olmo CA, McGettigan P, Kurz X. Barriers and opportunities for use of patient registries in medicines regulation. Clin Pharmacol Ther. 2019;106:39\u201342.","journal-title":"Clin Pharmacol Ther"},{"key":"619_CR12","unstructured":"US Food and Drug Administration. Assessing registries to support regulatory decision-making for drug and biological products guidance for industry: draft guidance. 2021. https:\/\/www.fda.gov\/media\/154449\/download. Accessed 9 Mar 2023."},{"key":"619_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1750-1172-9-81","volume":"9","author":"L Viviani","year":"2014","unstructured":"Viviani L, Zolin A, Mehta A, Olesen HV. The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry. Orphanet J Rare Dis. 2014;9:81.","journal-title":"Orphanet J Rare Dis"},{"key":"619_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s40271-021-00515-1","volume":"14","author":"WB Nowell","year":"2021","unstructured":"Nowell WB, Merkel PA, McBurney RN, Young K, Venkatachalam S, Shaw DG, et al. Patient-powered research networks of the Autoimmune Research Collaborative: rationale, capacity, and future directions. Patient. 2021;14:699\u2013710.","journal-title":"Patient"},{"key":"619_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7224\/1537-2073.2020-133","volume":"23","author":"RA Marrie","year":"2021","unstructured":"Marrie RA, Cutter GR, Fox RJ, Vollmer T, Tyry T, Salter A. NARCOMS and other registries in multiple sclerosis: issues and insights. The Consortium of Multiple Sclerosis Centers. Int J MS Care. 2021;23:276\u201384.","journal-title":"Int J MS Care."},{"key":"619_CR16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1371\/currents.RRN1309","volume":"4","author":"V Rangel","year":"2012","unstructured":"Rangel V, Martin AS, Peay HL. DuchenneConnect registry report. PLoS Curr. 2012;4:1309.","journal-title":"PLoS Curr."},{"key":"619_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13023-022-02200-4","volume":"17","author":"SC Bolton","year":"2022","unstructured":"Bolton SC, Soran V, Marfa MP, Imrie J, Gissen P, Jahnova H, et al. Clinical disease characteristics of patients with Niemann-Pick disease type C: findings from the International Niemann-Pick Disease Registry (INPDR). Orphanet J Rare Dis. 2022;17:51.","journal-title":"Orphanet J Rare Dis"},{"key":"619_CR18","doi-asserted-by":"publisher","first-page":"S497","DOI":"10.1016\/j.jval.2022.09.2466","volume":"25","author":"T Collin-Histed","year":"2022","unstructured":"Collin-Histed T, Milce J, Reed S, Braham-Chaouche L, Jaffe D, Revel-Vilk S, et al. SA73 addressing unmet needs of patients with neuronopathic Gaucher disease type 2 and type 3: creation of the GARDIAN Patient Registry. Value Health. 2022;25:S497.","journal-title":"Value Health."},{"key":"619_CR19","unstructured":"PIP UK. Poland Syndrome Community Register. https:\/\/pip-uk.org\/poland-syndrome-community-register. Accessed 25 Jan 2023."},{"key":"619_CR20","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1002\/acn3.51660","volume":"9","author":"L Rechtman","year":"2022","unstructured":"Rechtman L, Brenner S, Wright M, Ritsick M, Rahman F, Han M, et al. Impact of the National Amyotrophic Lateral Sclerosis Registry: analysis of registry-funded research. Ann Clin Transl Neurol. 2022;9:1692\u2013701.","journal-title":"Ann Clin Transl Neurol"},{"key":"619_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12883-016-0674-4","volume":"16","author":"S Friend","year":"2016","unstructured":"Friend S, Richman S, Bloomgren G, Cristiano LM, Wenten M. Evaluation of pregnancy outcomes from the Tysabri\u00ae (natalizumab) pregnancy exposure registry: a global, observational, follow-up study. BMC Neurol. 2016;16:150.","journal-title":"BMC Neurol"},{"key":"619_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00170\/abstract","author":"W Deeb","year":"2016","unstructured":"Deeb W, Rossi PJ, Porta M, Visser-Vandewalle V, Servello D, Silburn P, et al. The international deep brain stimulation registry and database for Gilles de la Tourette syndrome: how does it work? Front Neurosci. 2016. https:\/\/doi.org\/10.3389\/fnins.2016.00170\/abstract.","journal-title":"Front Neurosci."},{"key":"619_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13075-022-02955-y","volume":"24","author":"AS Padula","year":"2022","unstructured":"Padula AS, Pappas DA, Fiore S, Blachley TS, Ford K, Emeanuru K, et al. The effect of targeted rheumatoid arthritis therapeutics on systemic inflammation and anemia: analysis of data from the CorEvitas RA registry. Arthritis Res Ther. 2022;24:276.","journal-title":"Arthritis Res Ther"},{"key":"619_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3109\/21678421.2013.822516","volume":"14","author":"CB Brady","year":"2013","unstructured":"Brady CB, Trevor KT, Stein TD, Deykin EY, Perkins SD, Averill JG, et al. The Department of Veterans Affairs Biorepository Brain Bank: a national resource for amyotrophic lateral sclerosis research. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2013;14:591\u20137.","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration."},{"key":"619_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/10410236.2018.1536962","volume":"35","author":"N Kashian","year":"2020","unstructured":"Kashian N, Jacobson S. Factors of engagement and patient-reported outcomes in a stage IV breast cancer Facebook group. Health Commun. 2020;35:75\u201382.","journal-title":"Health Commun"},{"key":"619_CR26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.msard.2017.07.014","volume":"17","author":"S Eaneff","year":"2017","unstructured":"Eaneff S, Wang V, Hanger M, Levy M, Mealy MA, Brandt AU, et al. Patient perspectives on neuromyelitis optica spectrum disorders: data from the PatientsLikeMe online community. Multiple Scler Relat Disord. 2017;17:116\u201322.","journal-title":"Multiple Scler Relat Disord."},{"key":"619_CR27","volume-title":"Ensuring digital accessibility through process and policy","author":"J Lazar","year":"2015","unstructured":"Lazar J, Goldstein DF, Taylor A. Ensuring digital accessibility through process and policy. Amsterdam: Morgan Kaufmann\/Elsevier; 2015."},{"key":"619_CR28","volume-title":"Designing for the digital age: how to create human-centered products and services","author":"K Goodwin","year":"2009","unstructured":"Goodwin K. Designing for the digital age: how to create human-centered products and services. Indianapolis: Wiley Publications; 2009."},{"key":"619_CR29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.dib.2017.07.075","volume":"14","author":"D Lindoerfer","year":"2017","unstructured":"Lindoerfer D, Mansmann U. Data for the elaboration of the CIPROS checklist with items for a patient registry software system: examples and explanations. Data Brief. 2017;14:494\u20137.","journal-title":"Data Brief"},{"key":"619_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/978-3-319-57959-7","volume-title":"The eu general data protection regulation (GDPR): a practical guide, vol 10","author":"P Voigt","year":"2017","unstructured":"Voigt P, Von dem Bussche A. The eu general data protection regulation (GDPR): a practical guide, vol 10. 1st ed. Cham: Springer International Publishing; 2017. p. 10\u20135555.","edition":"1"},{"key":"619_CR31","unstructured":"US Department of Health and Human Services National Institute of Health. To whom does the privacy rule apply and whom will it affect? 2022. https:\/\/privacyruleandresearch.nih.gov\/pr_06.asp#:~:text=Covered%20entities%20are%20defined%20in,which%20HHS%20has%20adopted%20standards. Accessed 24 Oct 2022."},{"key":"619_CR32","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ejhg.2012.282","volume":"21","author":"KS Steinsbekk","year":"2013","unstructured":"Steinsbekk KS, K\u00e5reMyskja B, Solberg B. Broad consent versus dynamic consent in biobank research: is passive participation an ethical problem? Eur J Hum Genet. 2013;21:897\u2013902.","journal-title":"Eur J Hum Genet"},{"key":"619_CR33","unstructured":"Rose S. Planning for a zero trust architecture: a planning guide for Federal administrators. Gaithersburg (MD): National Institute of Standards and Technology; 2022: Report No.: NIST CSWP 20. https:\/\/nvlpubs.nist.gov\/nistpubs\/CSWP\/NIST.CSWP.20.pdf. Accessed 9 Mar 2023."},{"key":"619_CR34","first-page":"44","volume":"82","author":"K Stine","year":"2011","unstructured":"Stine K, Dang Q. Encryption basics. J Am Health Inform Manage Assoc. 2011;82:44\u20136.","journal-title":"J Am Health Inform Manage Assoc."},{"key":"619_CR35","unstructured":"Wikipedia. There are known knowns. 2022. https:\/\/en.wikipedia.org\/wiki\/There_are_known_knowns. Accessed 9 Mar 2023."},{"key":"619_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059707","volume":"8","author":"R Bove","year":"2013","unstructured":"Bove R, Secor E, Healy BC, Musallam A, Vaughan T, Glanz BI, et al. Evaluation of an online platform for multiple sclerosis research: patient description, validation of severity scale, and exploration of BMI effects on disease course. PLoS ONE. 2013;8: e59707.","journal-title":"PLoS ONE"},{"key":"619_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41746-022-00603-y","volume":"5","author":"N Goodson","year":"2022","unstructured":"Goodson N, Wicks P, Morgan J, Hashem L, Callinan S, Reites J. Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion. NPJ Digit Med. 2022;5:58.","journal-title":"NPJ Digit Med."},{"key":"619_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.msard.2016.06.015","volume":"9","author":"R Bove","year":"2016","unstructured":"Bove R, Vaughan T, Chitnis T, Wicks P, De Jager PL. Women\u2019s experiences of menopause in an online MS cohort: a case series. Mult Scler Relat Disord. 2016;9:56\u20139.","journal-title":"Mult Scler Relat Disord."},{"key":"619_CR39","volume-title":"Handbook of human computation","year":"2013","unstructured":"Michelucci P, editor. Handbook of human computation. New York: Springer; 2013."},{"key":"619_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g368","volume":"348","author":"P Wicks","year":"2014","unstructured":"Wicks P, Vaughan T, Heywood J. Subjects no more: what happens when trial participants realize they hold the power? BMJ. 2014;348: g368.","journal-title":"BMJ"},{"key":"619_CR41","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jcf.2010.08.018","volume":"9","author":"DN Sheppard","year":"2010","unstructured":"Sheppard DN. The European cystic fibrosis patient registry: the power of sharing data. J Cystic Fibrosis. 2010;9:S1-2.","journal-title":"J Cystic Fibrosis."},{"key":"619_CR42","doi-asserted-by":"publisher","first-page":"i9","DOI":"10.1136\/bmjqs-2013-002378","volume":"23","author":"MS Schechter","year":"2014","unstructured":"Schechter MS, Fink AK, Homa K, Goss CH. The Cystic Fibrosis Foundation Patient Registry as a tool for use in quality improvement. BMJ Qual Saf. 2014;23:i9-14.","journal-title":"BMJ Qual Saf"},{"key":"619_CR43","unstructured":"University of Florda Clinical and Translational Science Institute. REDCap pricing. 2022. https:\/\/www.ctsi.ufl.edu\/research\/study-design-and-analysis\/redcap\/redcap-pricing\/. Accessed 24 Oct 2022."},{"key":"619_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.15326\/jcopdf.1.1.2014.0122","volume":"1","author":"B Thomashow","year":"2014","unstructured":"Thomashow B, Walsh J, Malanga E. The COPD Foundation: celebrating a decade of progress and looking ahead to a cure. J COPD F. 2014;1:4\u201316.","journal-title":"J COPD F."},{"key":"619_CR45","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3109\/17482968.2010.484494","volume":"11","author":"RS Bedlack","year":"2010","unstructured":"Bedlack RS, Wicks P, Heywood J, Kasarskis E. Modifiable barriers to enrollment in American ALS research studies. Amyotrophic Lateral Scler. 2010;11:502\u20137.","journal-title":"Amyotrophic Lateral Scler"},{"key":"619_CR46","unstructured":"Politico. Suicide hotline shares data with for-profit spinoff, raising ethical questions. 2022. https:\/\/www.politico.com\/news\/2022\/01\/28\/suicide-hotline-silicon-valley-privacy-debates-00002617. Accessed 9 Mar 2023."},{"key":"619_CR47","unstructured":"Zhang S. Facebook groups as therapy. 2018. https:\/\/www.theatlantic.com\/technology\/archive\/2018\/10\/facebook-emotional-support-groups\/572941\/. Accessed 24 Oct 2022."},{"key":"619_CR48","unstructured":"Prior R. This breast cancer advocate says she discovered a Facebook flaw that put the health data of millions at risk. 2020. https:\/\/edition.cnn.com\/2020\/02\/29\/health\/andrea-downing-facebook-data-breach-wellness-trnd\/index.html. Accessed 24 Oct 2022."},{"key":"619_CR49","unstructured":"Ohlheiser A. Facebook is bombarding cancer patients with ads for unproven treatments. 2022. https:\/\/www.technologyreview.com\/2022\/06\/27\/1054784\/facebook-meta-cancer-treatment-ads-misinformation\/. Accessed 9 Mar 2023."},{"key":"619_CR50","unstructured":"Feathers T, Fondrie-Teitler S, Waller A, Mattu S. Facebook is receiving sensitive medical information from hospital websites. 2022. https:\/\/themarkup.org\/pixel-hunt\/2022\/06\/16\/facebook-is-receiving-sensitive-medical-information-from-hospital-websites. Accessed 24 Oct 2022."}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-023-00619-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-023-00619-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-023-00619-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T13:30:44Z","timestamp":1682083844000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40271-023-00619-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1007\/s40271-023-00619-w","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"22 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No specific funding was provided for this education article. SF\u2019s organization PIP-UK and AD\u2019s organization \u201cThe Light Collective\u201d received charitable donations from Wicks Digital Health Ltd in recognition of their time and effort.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"PW is an associate editor at the <i>Journal of Medical Internet Research<\/i> and is on the editorial advisory boards of the <i>BMJ<\/i>, <i>BMC Medicine<\/i>, <i>The Patient<\/i>, and <i>Digital Biomarkers<\/i>. PW is employed by Wicks Digital Health Ltd, which has received funding from Ada Health, AstraZeneca, Biogen, Bold Health, Camoni, Compass Pathways, Coronna, EIT, Endava, Happify, HealthUnlocked, Inbeeo, Kheiron Medical, Lindus Health, MedRhythms, PatientsLikeMe, Sano Genetics, Self Care Catalysts, The Learning Corp, The Wellcome Trust, THREAD Research, United Genomics, VeraSci, and Woebot. PW and spouse are shareholders of WDH Investments, Ltd., which owns stock in BlueSkeye AI Ltd, Earswitch Ltd, Sano Genetics Ltd, and Una Health Gmbh. EHD is an employee of Aparito and owns stock in the company. Aparito provides registry software. LWE is an employee of Sano Genetics, a technology company that provides registry software for third parties, including patient advocacy organizations. She owns stock in both Sano Genetics Ltd and Antidote Technologies Ltd. SF is an employee of PIP-UK. AD reports no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed to the manuscript conception and design. The first draft of the manuscript was written by PW and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}